MedPark Regeneration First

R&D

  • Technology

  • Facility

  • Certification

S1 Technology

Our Proprietary Original Technology

Composite bone grafting material composed of chemically and structurally treated
hydroxyapatite and additives with a natural structure similar to human bone.
It has osteoconductive Properties that aid bone regeneration at the grafted site.
This core technology is applicable to all medical fields (orthopedics, neurology, dentistry, etc.)
and various raw materials (xenogeneic, allogeneic, synthetic).

Facility

1st, 2nd, and 3rd Factory construction completed

World's First: European CE Certification for 3 Biomaterial Products
Separate Manufacturing Facilities for Different Raw Materials in Factories 1–3

  • 1st Factory / HQ

    [Bone Graft Material Line]
  • 2nd Factory / R&D Center

    [Bone Graft + Collagen Line]
  • 3rd Factory

    [Artificial Skin + Other Medical Field]

R&D Facilities / Certifications / Patents

Commercialized technology Global IP (intellectual property rights)
holding a total of 46 or more

Overseas
32

PCT application

4

US application

8

European application

8

China application

4

Taiwan application

6

Madrid trademark application

1

Chinese design application

1
0or more in total

Domestic
60

Domestic Patent

14

Domestic application

32

Domestic trademark registration

3

Domestic trademark application

5

Domestic design registration

3

Domestic design application

3